282 related articles for article (PubMed ID: 22048724)
1. Nitric oxide synthase derangements and hypertension in kidney disease.
Baylis C
Curr Opin Nephrol Hypertens; 2012 Jan; 21(1):1-6. PubMed ID: 22048724
[TBL] [Abstract][Full Text] [Related]
2. Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems.
Palm F; Onozato ML; Luo Z; Wilcox CS
Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3227-45. PubMed ID: 17933965
[TBL] [Abstract][Full Text] [Related]
3. Arginine, arginine analogs and nitric oxide production in chronic kidney disease.
Baylis C
Nat Clin Pract Nephrol; 2006 Apr; 2(4):209-20. PubMed ID: 16932427
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide deficiency in chronic kidney disease.
Baylis C
Am J Physiol Renal Physiol; 2008 Jan; 294(1):F1-9. PubMed ID: 17928410
[TBL] [Abstract][Full Text] [Related]
5. Renoprotective effects of melatonin in young spontaneously hypertensive rats with L-NAME.
Cheng MC; Wu TH; Huang LT; Tain YL
Pediatr Neonatol; 2014 Jun; 55(3):189-95. PubMed ID: 24268813
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of nitric oxide synthase uncoupling in endotoxin-induced acute lung injury: role of asymmetric dimethylarginine.
Sharma S; Smith A; Kumar S; Aggarwal S; Rehmani I; Snead C; Harmon C; Fineman J; Fulton D; Catravas JD; Black SM
Vascul Pharmacol; 2010; 52(5-6):182-90. PubMed ID: 19962451
[TBL] [Abstract][Full Text] [Related]
7. Enhancing kidney DDAH-1 expression by adenovirus delivery reduces ADMA and ameliorates diabetic nephropathy.
Wetzel MD; Gao T; Stanley K; Cooper TK; Morris SM; Awad AS
Am J Physiol Renal Physiol; 2020 Feb; 318(2):F509-F517. PubMed ID: 31904280
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation.
Dayoub H; Rodionov RN; Lynch C; Cooke JP; Arning E; Bottiglieri T; Lentz SR; Faraci FM
Stroke; 2008 Jan; 39(1):180-4. PubMed ID: 18063827
[TBL] [Abstract][Full Text] [Related]
9. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
[TBL] [Abstract][Full Text] [Related]
10. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
Feng M; Liu L; Guo Z; Xiong Y
Eur J Pharmacol; 2008 Apr; 584(1):49-56. PubMed ID: 18342305
[TBL] [Abstract][Full Text] [Related]
11. Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease.
Ueda S; Yamagishi SI; Matsumoto Y; Fukami K; Okuda S
Clin Exp Nephrol; 2007 Jun; 11(2):115-121. PubMed ID: 17593510
[TBL] [Abstract][Full Text] [Related]
12. Asymmetric dimethylarginine, endothelial dysfunction and renal disease.
Aldámiz-Echevarría L; Andrade F
Int J Mol Sci; 2012; 13(9):11288-11311. PubMed ID: 23109853
[TBL] [Abstract][Full Text] [Related]
13. Human recombinant erythropoietin augments serum asymmetric dimethylarginine concentrations but does not compromise nitric oxide generation in mice.
Desai A; Zhao Y; Warren JS
Nephrol Dial Transplant; 2008 May; 23(5):1513-20. PubMed ID: 18204093
[TBL] [Abstract][Full Text] [Related]
14. Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension.
Millatt LJ; Whitley GS; Li D; Leiper JM; Siragy HM; Carey RM; Johns RA
Circulation; 2003 Sep; 108(12):1493-8. PubMed ID: 12952847
[TBL] [Abstract][Full Text] [Related]
15. DDAH-2 alleviates contrast medium iopromide-induced acute kidney injury through nitric oxide synthase.
Lin HH; Lee TS; Lin SJ; Yeh YC; Lu TM; Hsu CP
Clin Sci (Lond); 2019 Dec; 133(23):2361-2378. PubMed ID: 31763675
[TBL] [Abstract][Full Text] [Related]
16. The DDAH/ADMA/NOS pathway.
Tran CT; Leiper JM; Vallance P
Atheroscler Suppl; 2003 Dec; 4(4):33-40. PubMed ID: 14664901
[TBL] [Abstract][Full Text] [Related]
17. Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease.
Matsumoto Y; Ueda S; Yamagishi S; Matsuguma K; Shibata R; Fukami K; Matsuoka H; Imaizumi T; Okuda S
J Am Soc Nephrol; 2007 May; 18(5):1525-33. PubMed ID: 17409314
[TBL] [Abstract][Full Text] [Related]
18. The DDAH-ADMA-NOS pathway.
Leiper JM
Ther Drug Monit; 2005 Dec; 27(6):744-6. PubMed ID: 16404814
[TBL] [Abstract][Full Text] [Related]
19. Aminoguanidine attenuates hypertension, whereas 7-nitroindazole exacerbates kidney damage in spontaneously hypertensive rats: the role of nitric oxide.
Huang CF; Hsu CN; Chien SJ; Lin YJ; Huang LT; Tain YL
Eur J Pharmacol; 2013 Jan; 699(1-3):233-40. PubMed ID: 23201071
[TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA).
Maas R
Vasc Med; 2005 Jul; 10 Suppl 1():S49-57. PubMed ID: 16444869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
